GeneThera GTHR Stock
GeneThera Price Chart
GeneThera GTHR Financial and Trading Overview
| GeneThera stock price | 0.0000 USD |
| Previous Close | 0.0085 USD |
| Open | 0.0085 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0085 - 0.0085 USD |
| 52 Week Range | 0.0061 - 0.04 USD |
| Volume | 1K USD |
| Avg. Volume | 2.57K USD |
| Market Cap | 300.33K USD |
| Beta (5Y Monthly) | 0.878169 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 17, 2007 |
| 1y Target Est | N/A |
GTHR Valuation Measures
| Enterprise Value | 1.14M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.684 |
Trading Information
GeneThera Stock Price History
| Beta (5Y Monthly) | 0.878169 |
| 52-Week Change | -63.51% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.04 USD |
| 52 Week Low | 0.0061 USD |
| 50-Day Moving Average | 0.00742 USD |
| 200-Day Moving Average | 0.01 USD |
GTHR Share Statistics
| Avg. Volume (3 month) | 2.57K USD |
| Avg. Daily Volume (10-Days) | 350 USD |
| Shares Outstanding | 35.33M |
| Float | 29.21M |
| Short Ratio | N/A |
| % Held by Insiders | 17.99% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -9537.97% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -677028 USD |
| Net Income Avi to Common (ttm) | -681262 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | 813.84K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.242 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12466 USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of GeneThera
| Country | United States |
| State | CO |
| City | Westminster |
| Address | 3051 West 105th Avenue |
| ZIP | 80035 |
| Phone | 720 587 5100 |
| Website | https://www.genethera.net |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. It offers treatments for zoonotic diseases, such as COVID -19 disease; paratuberculosis (Johne's disease) that is in Stage III clinical phase; mad cow and chronic wasting diseases; and E.coli and salmonella infections, as well as develops vaccine for mycobacterium avium sub paratuberculosis bacteria. The company's Molecular Robotic/AI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. GeneThera, Inc. is based in Westminster, Colorado.
Q&A For GeneThera Stock
What is a current GTHR stock price?
GeneThera GTHR stock price today per share is 0.0000 USD.
How to purchase GeneThera stock?
You can buy GTHR shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GeneThera?
The stock symbol or ticker of GeneThera is GTHR.
Which industry does the GeneThera company belong to?
The GeneThera industry is Biotechnology.
How many shares does GeneThera have in circulation?
The max supply of GeneThera shares is 0.
What is GeneThera Price to Earnings Ratio (PE Ratio)?
GeneThera PE Ratio is now.
What was GeneThera earnings per share over the trailing 12 months (TTM)?
GeneThera EPS is -0.02 USD over the trailing 12 months.
Which sector does the GeneThera company belong to?
The GeneThera sector is Healthcare.